NASAL DRUG DELIVERY

Conference Date: 14-15 Apr 2010
Conference Ref: N4-8010
Fee: £1280 + VAT
Venue: Le Meridien Piccadilly, London

THREE REASONS TO ATTEND THIS EVENT

1. Gain an update on the very latest scientific developments and technology advances in this field.
2. Hear from an unrivalled panel of expert speakers.
3. An excellent networking opportunity to build business relationships.

WHO SHOULD ATTEND

Managing Directors, Medical Directors, Head of Regulatory Affairs and Quality Assurance, Senior Executives in Research and Development, Registration, Marketing and all departments that may be involved in Nasal Drug Delivery, or who wish to understand the potential of this alternative therapeutic route. Those already involved in Nasal Drug Delivery will benefit from updating their knowledge and sharing experiences with some of the leading practitioners in this field. If you are involved in Nasal Drug Delivery or are just considering the potential, this conference is an excellent route to understanding all aspects from the basic physiology through to launching a successful product.

To be co-chaired by:
Day One: Professor Frans W H M Merkus Emeritus Professor of Biopharmaceutics, Leiden University, The Netherlands & Chairman of Innoscience Technology, Belgium
Day Two: Dr Julie Suman President, Next Breath LLC, USA
With a panel of key opinion leaders

Topics to be Covered:

• Beneficial and Adverse Effects of Intranasal Drug Administration
• The Effect of Nasal Physiology on Nasal Delivery
• Intranasal Opioid Analgesics and Opioid Antagonists – New Developments
• Intranasal Fentanyl and PainManagement
• The Use of Human Nasal Cell Cultures andMeasurement of Ciliary Movement to Optimise Nasal Drug Formulations
• Advances in Nasal and Sinonasal Drug Delivery Technology
• Mucosal Tolerization to E-Selectin by Intranasal Instillation for the Secondary Prevention of Stroke
• Have Nanotechnologies Got a Role in Nasal Drug Delivery?
• Understanding the Robustness of Operation of Nasal Pump Spray Devices
• Proven Technologies for Enhanced Nasal Drug and Vaccine Delivery
• Status and Future of the Bi-Directional Nasal Drug Delivery Concept
• Nasal Drug Delivery of Generic Drugs: Regulatory Aspects in Europe and in the USA
• EPAG Perspective - Regulatory Advances Related to Nasal Spray Pumps
• Nasal Toxicity Testing
• Intranasal Vaccination

To book your place on this important Annual event, please click here.